These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
869 related items for PubMed ID: 11555594
1. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas. Calogero A, Arcella A, De Gregorio G, Porcellini A, Mercola D, Liu C, Lombari V, Zani M, Giannini G, Gagliardi FM, Caruso R, Gulino A, Frati L, Ragona G. Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594 [Abstract] [Full Text] [Related]
2. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course. Watanabe T, Katayama Y, Yoshino A, Komine C, Yokoyama T. Clin Cancer Res; 2003 Oct 15; 9(13):4884-90. PubMed ID: 14581362 [Abstract] [Full Text] [Related]
3. p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma. Fulci G, Labuhn M, Maier D, Lachat Y, Hausmann O, Hegi ME, Janzer RC, Merlo A, Van Meir EG. Oncogene; 2000 Aug 03; 19(33):3816-22. PubMed ID: 10949938 [Abstract] [Full Text] [Related]
10. p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease. Omura-Minamisawa M, Diccianni MB, Chang RC, Batova A, Bridgeman LJ, Schiff J, Cohn SL, London WB, Yu AL. Clin Cancer Res; 2001 Nov 03; 7(11):3481-90. PubMed ID: 11705866 [Abstract] [Full Text] [Related]
11. INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene. Pinyol M, Hernández L, Martínez A, Cobo F, Hernández S, Beà S, López-Guillermo A, Nayach I, Palacín A, Nadal A, Fernández PL, Montserrat E, Cardesa A, Campo E. Am J Pathol; 2000 Jun 03; 156(6):1987-96. PubMed ID: 10854221 [Abstract] [Full Text] [Related]
13. Quantitative real-time PCR does not show selective targeting of p14(ARF) but concomitant inactivation of both p16(INK4A) and p14(ARF) in 105 human primary gliomas. Labuhn M, Jones G, Speel EJ, Maier D, Zweifel C, Gratzl O, Van Meir EG, Hegi ME, Merlo A. Oncogene; 2001 Mar 01; 20(9):1103-9. PubMed ID: 11314047 [Abstract] [Full Text] [Related]
16. Deregulation of the p14ARF/Mdm2/p53 pathway and G1/S transition in two glioblastoma sets. Ghimenti C, Fiano V, Chiadò-Piat L, Chiò A, Cavalla P, Schiffer D. J Neurooncol; 2003 Jan 01; 61(2):95-102. PubMed ID: 12622447 [Abstract] [Full Text] [Related]
17. Inactivation of the ARF-MDM-2-p53 pathway in sporadic Burkitt's lymphoma in children. Wilda M, Bruch J, Harder L, Rawer D, Reiter A, Borkhardt A, Woessmann W. Leukemia; 2004 Mar 01; 18(3):584-8. PubMed ID: 14712292 [Abstract] [Full Text] [Related]